Article
Rapid relief, good safety profile, long-term efficacy are advantages for highly effective drugs
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
ROP: Treating and preventing blindness in preterm babies
Study data show parental delay is biggest factor in late retinoblastoma diagnosis
Managing a changing landscape of IRD pediatric cases
Japanese researchers link outdoor time to rapid increase in choroidal thickness
Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access